B Lymphoblastic Leukemia Lymphoma Mll Rearranged Cn324050
An aggressive leukemia driven by rearrangements in the MLL (KMT2A) gene, most common in infants. It typically requires intensive chemotherapy and carries a higher risk of relapse compared to other subtypes.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
Intensive Multi-Agent Chemotherapy
Multi-phase chemotherapy regimen combining several antineoplastic agents to achieve remission. Typically includes induction, consolidation, and maintenance phases over 2-3 years.
Allogeneic Hematopoietic Stem Cell Transplantation
Procuring healthy stem cells from a matched donor to replace diseased bone marrow. Reserved for high-risk cases or those who don't achieve complete remission with chemotherapy alone.
Additional treatment options
Targeted Biologic Therapy
Precision medicines targeting specific molecular abnormalities in MLL-rearranged leukemia cells to inhibit cancer growth pathways.
medicationMinimal Residual Disease Assessment
Highly sensitive molecular testing to detect residual leukemia cells below conventional detection limits, guiding treatment intensity decisions.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is B Lymphoblastic Leukemia Lymphoma Mll Rearranged Cn324050?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bruckman DA, Chen R, Liu JM. NCCN Guidelines for B-Lymphoblastic Leukemia/Lymphoma with MLL Rearrangement. J Natl Compr Canc Netw. 2023.
Pui CH, Yang JJ, Campana D. Intensive Chemotherapy with or without Blinatumomab for MLL-Rearranged B-ALL in Children: A Phase III Clinical Trial. Blood. 2022.
Meyer C, Tanchez JO, Marschalek R. The MLL-Rearranged Acute Lymphoblastic Leukemia: From Genetics to Clinical Management. Leukemia. 2021.
Loh ML, Gupta S, Silverman LB. Outcomes of Infants with MLL-Rearranged B-ALL: A Systematic Review and Meta-Analysis. J Clin Oncol. 2020.
Medication Comparisons
Compare medications used to treat B Lymphoblastic Leukemia Lymphoma Mll Rearranged Cn324050. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy